HealthManagement, IQ_2012_06_venus

Trial: a study carried out with the purpose of testing a new medical treatment on a defined group of people. The results are compared with a group that are treated using another method and/or a control group.

Registry: a (retrospective) collection of data about a certain treatment or illness. using the compiled data, conclusions can be drawn about effectiveness of a particular treatment method.
 
Early Outcome of Mechanochemical Endovenous Ablation (ClariVein-2) 
Contact
Dr. Michel M.J. Reijnen, Rijnstate Hospital, NL
Date opened
November 2011
Status
Recruiting
Description
Mechanochemical endovenous ablation is a new tumescentless technique that combines a rotating wire with the infusion of a liquid sclerosant. The study aims to evaluate the short and long term outcome of mechanochemical endovenous ablation.
ClinicalTrials.gov Identifier: nCT01459263

Acute Venous Thrombosis: Thrombus Removal with adjunctive Catheter-Directed Thrombolysis (aTTRaCT)
Contact
Dr. Suresh Vedantham, Washington University School of Medicine, US
Date opened
November 2009
Status
Recruiting
Description
The purpose of this study is to determine if the use of ad junctive Pharmacomechanical Catheter Directed Thrombolysis can prevent the post-thrombotic syndrome (PTS) in patients with symptomatic proximal deep vein thrombosis (DVT).
ClinicalTrials.gov Identifier: nCT00790335

Pulmonary Embolism Response to Fragmentation, Embolectomy & Catheter Thrombolysis: Perfect
Contact
Mr. William T. Kuo, Stanford University School of Medicine, US
Date opened
January 2011
Status
Not yet recruiting
Description
A prospective observational study to evaluate the safety and effectiveness of catheter-directed therapy (CDT) including percutaneous mechanical thrombectomy (PMT) for treatment of acute pulmonary embolism (PE).
ClinicalTrials.gov Identifier: nCT01459263

Ultrasound-Enhanced Thrombolysis versus standard Catheter Directed Thrombolysis for Ilio-Femoral Deep Vein Thrombosis
Contact
Dr. Nils Kucher, University Hospital and University of Bern, CH
Date opened
November 2011
Status
Recruiting
Description
The hypothesis for this study is that ultrasound-enhanced thrombolysis reaches a higher degree of thrombolysis than standard catheter-directed thrombolysis (CDT) in patients with symptomatic ilio-femoral Deep Vein Thrombosis (DVT).
ClinicalTrials.gov Identifier: nCT01482273

Ultrasound Accelerated ThrombolysIs of Pulmonary Embolism (uLTIMa)
Contact
Dr. Nils Kucher, University Hospital and University of Bern, CH
Date opened
July 2010
Status
Recruiting
Description
The ULTIMA study is intended to prove that patients with pulmonary embolism and a right ventricular end diastolic diameter to left ventricular end diastolic diameter ratio ≥1 (RV/LV ratio) will benefit from treatment with ultrasound accelerated thrombolysis (rt-PA) as compared to anti coagulation.
ClinicalTrials.gov Identifier: nCT01166997

IQ takes no responsibility for the content of the individual trials and registries; please refer to their source for further information.
Please note, this does not constitute an exhaustive overview of trials and registries. If you are aware of a trial or registry which may be of interest to our readers,
please feel free to contact us at [email protected].

«« Technological Breakthrough in Early Disease Detection


Northern Ireland Takes Lead in Deployment of Nationwide Electronic Care Record »»